These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28951832)

  • 1. Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy.
    Brown JA; Hua AY; Trujllo A; Attygalle S; Binney RJ; Spina S; Lee SE; Kramer JH; Miller BL; Rosen HJ; Boxer AL; Seeley WW
    Neuroimage Clin; 2017; 16():564-574. PubMed ID: 28951832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disrupted resting-state functional connectivity in progressive supranuclear palsy.
    Piattella MC; Tona F; Bologna M; Sbardella E; Formica A; Petsas N; Filippini N; Berardelli A; Pantano P
    AJNR Am J Neuroradiol; 2015 May; 36(5):915-21. PubMed ID: 25655870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic functional connectivity alterations in progressive supranuclear palsy: Differential effects in frontal cortex, motor, and midbrain networks.
    Rosskopf J; Gorges M; Müller HP; Lulé D; Uttner I; Ludolph AC; Pinkhardt E; Juengling FD; Kassubek J
    Mov Disord; 2017 Jul; 32(7):1006-1015. PubMed ID: 28544256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disrupted thalamocortical connectivity in PSP: a resting-state fMRI, DTI, and VBM study.
    Whitwell JL; Avula R; Master A; Vemuri P; Senjem ML; Jones DT; Jack CR; Josephs KA
    Parkinsonism Relat Disord; 2011 Sep; 17(8):599-605. PubMed ID: 21665514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic connectivity network disruption in progressive supranuclear palsy.
    Gardner RC; Boxer AL; Trujillo A; Mirsky JB; Guo CC; Gennatas ED; Heuer HW; Fine E; Zhou J; Kramer JH; Miller BL; Seeley WW
    Ann Neurol; 2013 May; 73(5):603-16. PubMed ID: 23536287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor imaging and voxel based morphometry study in early progressive supranuclear palsy.
    Padovani A; Borroni B; Brambati SM; Agosti C; Broli M; Alonso R; Scifo P; Bellelli G; Alberici A; Gasparotti R; Perani D
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):457-63. PubMed ID: 16306152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
    Josephs KA; Xia R; Mandrekar J; Gunter JL; Senjem ML; Jack CR; Whitwell JL
    Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes.
    Gilman S; Koeppe RA; Nan B; Wang CN; Wang X; Junck L; Chervin RD; Consens F; Bhaumik A
    Neurology; 2010 May; 74(18):1416-23. PubMed ID: 20439843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Brain; 2006 Apr; 129(Pt 4):1040-9. PubMed ID: 16455792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo distribution of brain tissue loss in Richardson's syndrome and PSP-parkinsonism: a VBM-DARTEL study.
    Agosta F; Kostić VS; Galantucci S; Mesaros S; Svetel M; Pagani E; Stefanova E; Filippi M
    Eur J Neurosci; 2010 Aug; 32(4):640-7. PubMed ID: 20597976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR imaging of brainstem atrophy in progressive supranuclear palsy.
    Slowinski J; Imamura A; Uitti RJ; Pooley RA; Strongosky AJ; Dickson DW; Broderick DF; Wszolek ZK
    J Neurol; 2008 Jan; 255(1):37-44. PubMed ID: 18080856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the rostral midbrain atrophy in progressive supranuclear palsy.
    Kato N; Arai K; Hattori T
    J Neurol Sci; 2003 Jun; 210(1-2):57-60. PubMed ID: 12736089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of brain activity in progressive supranuclear palsy and Parkinson's disease.
    Burciu RG; Ofori E; Shukla P; Planetta PJ; Snyder AF; Li H; Hass CJ; Okun MS; McFarland NR; Vaillancourt DE
    Mov Disord; 2015 Aug; 30(9):1248-58. PubMed ID: 26148135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.
    Whitwell JL; Tosakulwong N; Botha H; Ali F; Clark HM; Duffy JR; Utianski RL; Stevens CA; Weigand SD; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Ahlskog JE; Dickson DW; Josephs KA
    Neuroimage Clin; 2020; 25():102152. PubMed ID: 31935638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voxel based morphometry reveals a distinct pattern of frontal atrophy in progressive supranuclear palsy.
    Brenneis C; Seppi K; Schocke M; Benke T; Wenning GK; Poewe W
    J Neurol Neurosurg Psychiatry; 2004 Feb; 75(2):246-9. PubMed ID: 14742598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.